Correlation Between Dermata Therapeutics and Augmedix

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and Augmedix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and Augmedix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics Warrant and Augmedix, you can compare the effects of market volatilities on Dermata Therapeutics and Augmedix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of Augmedix. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and Augmedix.

Diversification Opportunities for Dermata Therapeutics and Augmedix

-0.16
  Correlation Coefficient

Good diversification

The 3 months correlation between Dermata and Augmedix is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics Warrant and Augmedix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Augmedix and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics Warrant are associated (or correlated) with Augmedix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Augmedix has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and Augmedix go up and down completely randomly.

Pair Corralation between Dermata Therapeutics and Augmedix

Assuming the 90 days horizon Dermata Therapeutics Warrant is expected to generate 14.45 times more return on investment than Augmedix. However, Dermata Therapeutics is 14.45 times more volatile than Augmedix. It trades about 0.15 of its potential returns per unit of risk. Augmedix is currently generating about 0.05 per unit of risk. If you would invest  1.50  in Dermata Therapeutics Warrant on August 30, 2024 and sell it today you would lose (0.62) from holding Dermata Therapeutics Warrant or give up 41.33% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy62.5%
ValuesDaily Returns

Dermata Therapeutics Warrant  vs.  Augmedix

 Performance 
       Timeline  
Dermata Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Solid
Over the last 90 days Dermata Therapeutics Warrant has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly abnormal basic indicators, Dermata Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Augmedix 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Good
Over the last 90 days Augmedix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong technical and fundamental indicators, Augmedix is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Dermata Therapeutics and Augmedix Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dermata Therapeutics and Augmedix

The main advantage of trading using opposite Dermata Therapeutics and Augmedix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, Augmedix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Augmedix will offset losses from the drop in Augmedix's long position.
The idea behind Dermata Therapeutics Warrant and Augmedix pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk